|
|
||||||||
1From the Departments of Physiology and Biophysics, 2Ophthalmology, 3Oncology, 4Dermatology, and 5Biochemistry, Case School of Medicine, Cleveland, Ohio.
PURPOSE. Understanding the mechanisms that regulate gene expression in the human cornea is an important goal. In the present study, the involucrin gene was used as a model to study this regulation. Human involucrin (hINV) is a structural protein that is selectively expressed in surface epithelia, including corneal epithelial cells.
METHODS. Regulation of involucrin gene expression was monitored in cultures of normal human primary corneal epithelial cells.
RESULTS. The studies revealed that an activator protein (AP)-1 DNA-binding site is essential for appropriate basal and stimulus-dependent hINV promoter activity. Mutation of this site, AP1-1, results in a loss of hINV promoter activity. A gel mobility supershift analysis revealed interaction of the AP1 factors, Fra-1, Fra-2, and JunB, with this element. Inhibition of AP1 function with a dominant-negative form of AP1 also inhibited expression. Treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C activator, increased hINV gene expression, a response that correlates with increased nuclear AP1 factor level and binding to the hINV gene AP1-1 response element. Expression of the endogenous hINV gene is also increased by TPA treatment.
CONCLUSIONS. These findings point to an important role for AP1 transcription factors in the regulation of human corneal epithelial cell involucrin gene expression.
This article has been cited by other articles:
![]() |
Y. Sun, T. Fox, G. Adhikary, M. Kester, and E. Pearlman Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide J. Leukoc. Biol., June 1, 2008; 83(6): 1512 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Yoon, C. S. De Paiva, H. Qi, Z. Chen, W. J. Farley, D.-Q. Li, and S. C. Pflugfelder Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2561 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. De Paiva, R. M. Corrales, A. L. Villarreal, W. Farley, D.-Q. Li, M. E. Stern, and S. C. Pflugfelder Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2847 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tong, R. M. Corrales, Z. Chen, A. L. Villarreal, C. S. De Paiva, R. Beuerman, D.-Q. Li, and S. C. Pflugfelder Expression and Regulation of Cornified Envelope Proteins in Human Corneal Epithelium Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1938 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hori, S. J. Spurr-Michaud, C. L. Russo, P. Argueso, and I. K. Gipson Effect of Retinoic Acid on Gene Expression in Human Conjunctival Epithelium: Secretory Phospholipase A2 Mediates Retinoic Acid Induction of MUC16 Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4050 - 4061. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Adhikary, J. F. Crish, R. Gopalakrishnan, F. Bone, and R. L. Eckert Involucrin Expression in the Corneal Epithelium: An Essential Role for Sp1 Transcription Factors Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3109 - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Adhikary, J. F. Crish, F. Bone, R. Gopalakrishnan, J. Lass, and R. L. Eckert An Involucrin Promoter AP1 Transcription Factor Binding Site Is Required for Expression of Involucrin in the Corneal Epithelium In Vivo Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1219 - 1227. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |